Skip to main content
. 2020 Jul 9;14:1753466620938553. doi: 10.1177/1753466620938553

Figure 8.

Figure 8.

Characterization of the response with larotrectinib in the phase I and II study sequence (including the NAVIGATE basket study), with respect to the threshold obtained with previously used diverse conventional interventions.